Global Acorus Calamus Rhizome Extract Market Strategic Research Report
By Type: Volatile Oil Content: <1%, Volatile Oil Content: 1%–3%, Volatile Oil Content: ≥3%
By Application: Personal Care Products, Cosmetics, Others
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: ICHIMARU PHARCOS(JP), KOEI KOGYO(JP), Maruzen Pharmaceuticals(JP), Wellgreen Herb(CN), Wuhan Lingben Technology(CN), Vigorous-Tech(CN), Sinochem Nanjing(CN), Hunan E.K Herb(CN), Bolise / BKHerb(CN), Vantage(US), Berjé(US), Mother Herbs(IN), Kisalaya Herbals(IN), Vivaan Herbals(IN), Navchetana Kendra(IN), Bioveda Naturals(IN), Chemcopia Ingredients(IN), Pharmika India(IN), FLAVEX Naturextrakte(DE), CONIUNCTA(DE), L.E.V. / Ekstraktu Rupnica(LV), Durae Corporation(KR), Natural Solution(KR), Dermalab(KR), COSEEDBIOPHARM(KR)
개요
Scope of the Report
The global Acorus Calamus Rhizome Extract market size is predicted to grow from US$ 157 million in 2025 to US$ 264 million in 2032; it is expected to grow at a CAGR of 7.8% from 2026 to 2032.
Acorus calamus rhizome extract refers to a mixture of plant-derived active ingredients obtained from the dried rhizomes of plants belonging to the *Acorus* genus (family Araceae) through processes such as solvent extraction, aqueous extraction, or supercritical fluid extraction. It primarily contains volatile oils (such as α-asarone and β-asarone), flavonoids, and various terpenoid compounds. Possessing biological activities such as antioxidant, sedative-soothing, and skin-conditioning properties, it is frequently utilized in traditional herbal medicine formulations, functional cosmetics, and aromatherapy products.
The value chain for Acorus calamus rhizome extract comprises three segments: upstream cultivation and raw material supply (involving cultivation bases, wild harvesting, and seedling propagation); midstream extraction and processing (producing volatile oils and standardized extracts via steam distillation, solvent extraction, or supercritical CO₂ processes); and downstream applications (encompassing traditional Chinese medicine formulations, functional cosmetics, aromatherapy products, and certain dietary supplement formulators). Specifically, the upstream raw material cultivation segment is subject to geographical dependency and fluctuations in active ingredient content; consequently, it exhibits relatively low overall added value, with gross margins typically ranging from 15% to 30%. The midstream extraction and processing segment—due to its involvement in volatile oil separation and active ingredient standardization—faces high technical barriers; its gross margins generally range from 35% to 60%. Conversely, the downstream branding and formulation segment—leveraging efficacy claims and brand premiums—can achieve gross margins of 50% to 80%. Overall, the industry structure is characterized by "low margins at the raw material end, technology-driven value creation in the midstream, and high added value at the downstream branding end."
In 2025, the average price of Acorus calamus rhizome extract is projected to be US$110,000 per ton, with a sales volume of 1,454 tons and a total production capacity of 2,077 tons.
Within the realm of functional botanical ingredients, Acorus calamus rhizome extract embodies a distinctive dual nature: a foundation rooted in traditional medicinal usage, coupled with modern extensions of its application. Its core value stems from the biological activities conferred by its volatile oil constituents—particularly compounds such as asarone ethers—which exhibit sedative, antioxidant, and certain neuromodulatory properties. This profile establishes a solid foundation for its consistent application in Traditional Chinese Medicine formulations, aromatherapy, and soothing skincare products. From an industrial perspective, the utilization of this extract remains predominantly empirical; standardized validation of its mechanisms of action and the accumulation of clinical data are currently relatively limited. Furthermore, its consistency and suitability for large-scale application face significant challenges due to variations in raw material origin and plant variety, as well as the inherent instability of its volatile components. Nevertheless, driven by advancements in the analysis of botanical active ingredients, the refinement of standardized extraction processes, and the growing trend of "emotional wellness" within functional cosmetics, *Acorus* rhizome extract is poised to evolve from a traditional herbal auxiliary ingredient into a sophisticated botanical active ingredient with clearly defined functional attributes.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Acorus Calamus Rhizome Extract market?
What factors are driving Acorus Calamus Rhizome Extract market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Acorus Calamus Rhizome Extract market opportunities vary by end market size?
How does Acorus Calamus Rhizome Extract break out by Type, by Application?
This report presents a comprehensive overview of the global Acorus Calamus Rhizome Extract market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Volatile Oil Content: <1%
- Volatile Oil Content: 1%–3%
- Volatile Oil Content: ≥3%
Segment by Grade
- Pharmaceutical Grade
- Cosmetic Grade
- Aromatherapy Grade
Segment by Product Form
- Crude Extract
- Standardized Extract
- Essential Oil Grade
Segment by Application
- Personal Care Products
- Cosmetics
- Others
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Acorus Calamus Rhizome Extract market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Personal Care Products, Cosmetics, Others evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Acorus Calamus Rhizome Extract Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Volatile Oil Content: <1%
- 3.1.3 Volatile Oil Content: 1%–3%
- 3.1.4 Volatile Oil Content: ≥3%
- 3.1.5 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Personal Care Products
- 4.1.3 Cosmetics
- 4.1.4 Others
- 4.1.5 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 ICHIMARU PHARCOS(JP)
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 KOEI KOGYO(JP)
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Maruzen Pharmaceuticals(JP)
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Wellgreen Herb(CN)
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Wuhan Lingben Technology(CN)
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Vigorous-Tech(CN)
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Sinochem Nanjing(CN)
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Hunan E.K Herb(CN)
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Bolise / BKHerb(CN)
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Vantage(US)
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Berjé(US)
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Mother Herbs(IN)
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Kisalaya Herbals(IN)
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Vivaan Herbals(IN)
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
- 8.15 Navchetana Kendra(IN)
- 8.15.1 Company Overview
- 8.15.2 Key Products & Segments
- 8.15.3 Financial Performance (2023–2025)
- 8.15.4 Business Strategy
- 8.15.5 SWOT Analysis
- 8.15.6 Strategic Implications (2026–2032)
- 8.16 Bioveda Naturals(IN)
- 8.16.1 Company Overview
- 8.16.2 Key Products & Segments
- 8.16.3 Financial Performance (2023–2025)
- 8.16.4 Business Strategy
- 8.16.5 SWOT Analysis
- 8.16.6 Strategic Implications (2026–2032)
- 8.17 Chemcopia Ingredients(IN)
- 8.17.1 Company Overview
- 8.17.2 Key Products & Segments
- 8.17.3 Financial Performance (2023–2025)
- 8.17.4 Business Strategy
- 8.17.5 SWOT Analysis
- 8.17.6 Strategic Implications (2026–2032)
- 8.18 Pharmika India(IN)
- 8.18.1 Company Overview
- 8.18.2 Key Products & Segments
- 8.18.3 Financial Performance (2023–2025)
- 8.18.4 Business Strategy
- 8.18.5 SWOT Analysis
- 8.18.6 Strategic Implications (2026–2032)
- 8.19 FLAVEX Naturextrakte(DE)
- 8.19.1 Company Overview
- 8.19.2 Key Products & Segments
- 8.19.3 Financial Performance (2023–2025)
- 8.19.4 Business Strategy
- 8.19.5 SWOT Analysis
- 8.19.6 Strategic Implications (2026–2032)
- 8.20 CONIUNCTA(DE)
- 8.20.1 Company Overview
- 8.20.2 Key Products & Segments
- 8.20.3 Financial Performance (2023–2025)
- 8.20.4 Business Strategy
- 8.20.5 SWOT Analysis
- 8.20.6 Strategic Implications (2026–2032)
- 8.21 L.E.V. / Ekstraktu Rupnica(LV)
- 8.21.1 Company Overview
- 8.21.2 Key Products & Segments
- 8.21.3 Financial Performance (2023–2025)
- 8.21.4 Business Strategy
- 8.21.5 SWOT Analysis
- 8.21.6 Strategic Implications (2026–2032)
- 8.22 Durae Corporation(KR)
- 8.22.1 Company Overview
- 8.22.2 Key Products & Segments
- 8.22.3 Financial Performance (2023–2025)
- 8.22.4 Business Strategy
- 8.22.5 SWOT Analysis
- 8.22.6 Strategic Implications (2026–2032)
- 8.23 Natural Solution(KR)
- 8.23.1 Company Overview
- 8.23.2 Key Products & Segments
- 8.23.3 Financial Performance (2023–2025)
- 8.23.4 Business Strategy
- 8.23.5 SWOT Analysis
- 8.23.6 Strategic Implications (2026–2032)
- 8.24 Dermalab(KR)
- 8.24.1 Company Overview
- 8.24.2 Key Products & Segments
- 8.24.3 Financial Performance (2023–2025)
- 8.24.4 Business Strategy
- 8.24.5 SWOT Analysis
- 8.24.6 Strategic Implications (2026–2032)
- 8.25 COSEEDBIOPHARM(KR)
- 8.25.1 Company Overview
- 8.25.2 Key Products & Segments
- 8.25.3 Financial Performance (2023–2025)
- 8.25.4 Business Strategy
- 8.25.5 SWOT Analysis
- 8.25.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the current global Acorus Calamus Rhizome Extract market size?
What growth rate is expected for the Acorus Calamus Rhizome Extract market through 2032?
How is Acorus Calamus Rhizome Extract defined?
What are the main segments of the Acorus Calamus Rhizome Extract market by type?
Which applications drive demand in the Acorus Calamus Rhizome Extract market?
Who are the key players in the Acorus Calamus Rhizome Extract market?
Which regions and countries are covered for Acorus Calamus Rhizome Extract?
What is driving growth in the Acorus Calamus Rhizome Extract market?
What challenges does the Acorus Calamus Rhizome Extract market face?
Who should buy the Acorus Calamus Rhizome Extract market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Acorus Calamus Rhizome Extract Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Chemicals & Advanced Materials